510(k) K260429

Control-IQ+ technology by Tandem Diabetes Care, Inc. — Product Code QJI

K260429 is an FDA 510(k) premarket notification submitted by Tandem Diabetes Care, Inc. for the device "Control-IQ+ technology". The FDA issued a decision of Substantially Equivalent on Apr 24, 2026. The device falls under product code QJI (Interoperable Automated Glycemic Controller), a Class II device regulated under 21 CFR 862.1356. Tandem Diabetes Care, Inc. has 25 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Apr 24, 2026
Date Received
Feb 10, 2026
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Interoperable Automated Glycemic Controller
Device Class
Class II
Regulation Number
862.1356
Review Panel
CH
Submission Type
510(k)

An interoperable automated glycemic controller is a device intended to automatically calculate drug doses based on inputs such as glucose and other relevant physiological parameters, and to command the delivery of such drug doses from a connected infusion pump. Interoperable automated glycemic controllers are designed to reliably and securely communicate with digitally connected devices to allow drug delivery commands to be sent, received, executed, and confirmed. Interoperable automated glycemic controllers are intended to be used in conjunction with digitally connected devices for the purpose of maintaining glycemic control.

Need the full FDA record for Tandem Diabetes Care, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K260429. Report a data issue: hello@regdatalab.com.